Table 1 Information on the patient tissue used in the studies
From: Reassessment of Neuronal Tau Distribution in Adult Human Brain and Implications for Tau Pathobiology
Cases | Neurological diagnosis | Primary neuropathological diagnosis | Secondary neuropathological diagnosis | Thal | Braak | CERAD | APOE | Sex | Age |
|---|---|---|---|---|---|---|---|---|---|
CTL-1 | Â | CVD | AD low | 1 | II | none | 3/3 | F | 90 |
CTL-2 | Â | PART, Braak I | CAA widespread, moderate | 0 | I | none | 3/3 | M | 71 |
CTL-3 | Â | PART, Braak II | Â | 0 | II | none | 3/3 | F | 72 |
AD-1 | AD | AD high | CAA widespread, mild | 4 | V | frequent | 3/4 | M | 77 |
AD-2 | AD | AD high | CAA widespread, severe | 5 | V | frequent | 3/4 | F | 72 |
AD-3 | AD | AD high | CAA widespread, moderate | 5 | VI | frequent | 3/4 | M | 63 |